Skip to content

Red Light Intervention for Myopia Prevention

A Randomized Controlled Trial of Low-dose Single-wavelength Red Light in the Decrease of Myopia Incidence Rate in the Setting of School.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04825769
Enrollment
278
Registered
2021-04-01
Start date
2021-03-25
Completion date
2022-08-31
Last updated
2022-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

Children and adolescents, Myopia, Prevention and control, Red light

Brief summary

To explore the effectiveness of using low-intensity single-wavelength red light to prevent myopia in schoolchildren, and to provide a feasible scheme for reducing the incidence of myopia.

Interventions

DEVICELLLT(Low Level Laser Therapy)

2 times a day, 3 minutes each time, with an interval of more than 4 hours. During the semester: From Monday to Friday, set up an intervention room in the school; For winter and summer vacation: everyday at home

Sponsors

Shanghai Eye Disease Prevention and Treatment Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 11 Years
Healthy volunteers
No

Inclusion criteria

* Students of grade 1-4 in the participating schools; * Students' eyes have no myopia, that is the cycloplegic spherical equivalent(SE) \>-0.50D, and at least one eye accords with the pre-myopic state, that is -0.50D \<cycloplegic SE≤0.50D; * Students whose mother and/or father are in myopia status (SE \< -3.0D for either of eyes); * Students whose parents sign informed consent and agree to let their kids participate in baseline screen and follow-up examinations and surveys.

Exclusion criteria

* Students whose parents do not sign informed consent; * Students who have strabismus and/or other binocular vision abnormality; * Students who have other eye diseases and/or systematic diseases; * Students who have DC \<=-1.5D; * Students whose difference of SE between the two eyes \>=1.5D; * Students who meet the standards with which investigators and study physicians think it is not appropriate to enroll.

Design outcomes

Primary

MeasureTime frameDescription
One-year cumulative incidence of myopia (%) in the intervention group and the control group.1 yearMyopia is defined as the cycloplegic spherical equivalent of either eye ≤-0.5D

Secondary

MeasureTime frameDescription
The progress of spherical equivalent(SE,D) of children in intervention group and control group.1 yearThe spherical equivalent(SE,D) will be measured by autorefractor(KR-8900, Topcon).
The progress of axial length of children in intervention group and control group.1 yearThe axial length will be measured using IOLMaster.
The progress of choroidal thickness in children in pre-myopia state in intervention group and control group.1 yearThe choroidal thickness will be measured using SS-OCT.
The change of uncorrected visual acuity (UCVA) of children in intervention group and control group.1 yearThe uncorrected visual acuity (UCVA) will be measured using a mounted and illuminated E chart of the Early Treatment Diabetic Retinopathy study (ETDRS) charts.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026